Smaller doses for perioral treatment than for upper facial applications are applied as the oral musculature responds more strongly to the exact same BTX-A dosing. Just one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole sign and FDA acceptance lies in treatments of cervical dystonia. While nasolabial folds are